Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01984164 · ClinicalTrials.gov registry record · Phase 2
CAndesartan vs LIsinopril Effects on the BRain
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 176
- Enrollment target
NCT01984164 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 176 participants.
The verdict
NCT01984164, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 176 participants
- Enrollment target
Study Summary
The aim of this study is to conduct a 1-year double blind randomized control trial comparing candesartan to lisinopril in 140 individuals with hypertension and executive mild cognitive impairment in their effects on executive function, neuroimaging markers, and vascular indicators.
Interventions
- DRUG Lisinopril
- DRUG Candesartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2014-08-20 |
| Est. Completion | 2018-12-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01984164
The ClinicalTrials.gov registry entry for NCT01984164 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lisinopril is the first listed.
NCT01984164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01984164 about?
NCT01984164 is a clinical study titled "CAndesartan vs LIsinopril Effects on the BRain". The aim of this study is to conduct a 1-year double blind randomized control trial comparing candesartan to lisinopril in 140 individuals with hypertension and executive mild cognitive impairment in their effects on executive function, neuroimaging markers, and vascular indicators.
What is the current status of trial NCT01984164?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 176 participants. The study started on 2014-08-20. Estimated completion is 2018-12-03.
What interventions are being tested in trial NCT01984164?
The interventions under investigation include: Lisinopril (DRUG), Candesartan (DRUG).
Who is sponsoring clinical trial NCT01984164?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.